Abhinav Anand

785 total citations
48 papers, 380 citations indexed

About

Abhinav Anand is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Abhinav Anand has authored 48 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 26 papers in Hepatology and 17 papers in Surgery. Recurrent topics in Abhinav Anand's work include Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (20 papers) and Pancreatitis Pathology and Treatment (8 papers). Abhinav Anand is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (20 papers) and Pancreatitis Pathology and Treatment (8 papers). Abhinav Anand collaborates with scholars based in India, United States and Grenada. Abhinav Anand's co-authors include S. Shalimar, Anoop Saraya, Deepak Gunjan, Samagra Agarwal, Anshuman Elhence, Srikant Mohta, Sanchit Sharma, Amit Goel, Namrata Singh and Kanav Kaushal and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Abhinav Anand

42 papers receiving 372 citations

Peers

Abhinav Anand
Tudor Cuciureanu Romania
Vanesa Bernal Monterde Spain
Preetam Nath India
Truls Sanengen Norway
Josephine Grace Australia
Neven Franjić Croatia
Savio John United States
Nobuhiro Hattori Japan
Ian Johnston United Kingdom
D. Cappello Italy
Tudor Cuciureanu Romania
Abhinav Anand
Citations per year, relative to Abhinav Anand Abhinav Anand (= 1×) peers Tudor Cuciureanu

Countries citing papers authored by Abhinav Anand

Since Specialization
Citations

This map shows the geographic impact of Abhinav Anand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhinav Anand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhinav Anand more than expected).

Fields of papers citing papers by Abhinav Anand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhinav Anand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhinav Anand. The network helps show where Abhinav Anand may publish in the future.

Co-authorship network of co-authors of Abhinav Anand

This figure shows the co-authorship network connecting the top 25 collaborators of Abhinav Anand. A scholar is included among the top collaborators of Abhinav Anand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abhinav Anand. Abhinav Anand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Biswas, Sagnik, Abhinav Anand, Umang Arora, et al.. (2024). Comparison of 1‐day versus 3‐day intravenous terlipressin in cirrhosis patients with variceal bleeding: A pilot randomised controlled trial. Alimentary Pharmacology & Therapeutics. 59(5). 645–655. 7 indexed citations
3.
Anand, Abhinav, S. Shalimar, Umang Arora, et al.. (2023). ABDA Score: A Non-invasive Model to Identify Subjects with Fibrotic Non-alcoholic Steatohepatitis in the Community. Journal of Clinical and Experimental Hepatology. 13(5). 742–752. 3 indexed citations
4.
Biswas, Sagnik, Abhinav Anand, Umang Arora, et al.. (2023). Hepatic Venous Pressure Gradient Predicts Further Decompensation in Cirrhosis Patients with Acute Esophageal Variceal Bleeding. Diagnostics. 13(14). 2385–2385. 2 indexed citations
5.
Elhence, Anshuman, Abhinav Anand, Sagnik Biswas, et al.. (2022). Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria. Digestive Diseases and Sciences. 68(3). 1016–1025. 5 indexed citations
6.
Anand, Abhinav, et al.. (2022). Prevalence and risk factors of bone disease in patients with chronic pancreatitis: a cross sectional study. International Journal of Research in Medical Sciences. 10(8). 1644–1644. 1 indexed citations
7.
Elhence, Anshuman, Sagnik Biswas, Abhinav Anand, et al.. (2021). The Outcome in Cirrhosis after Hospital Discharge is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. Journal of Clinical and Experimental Hepatology. 12(3). 830–840. 3 indexed citations
8.
Anand, Abhinav, et al.. (2021). Hepatic Infarction after Transjugular Intrahepatic Shunt Creation. Journal of Vascular and Interventional Radiology. 32(10). 1513–1513. 1 indexed citations
9.
Anand, Abhinav, Anshuman Elhence, Sagnik Biswas, et al.. (2021). Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology. 12(2). 362–371. 3 indexed citations
10.
Elhence, Anshuman, Achintya D. Singh, Abhinav Anand, et al.. (2021). Real‐world re‐treatment outcomes of direct‐acting antiviral therapy failure in patients with chronic hepatitis C. Journal of Medical Virology. 93(8). 4982–4991. 9 indexed citations
11.
Anand, Abhinav & S. Shalimar. (2021). Hepatitis C virus in India: Challenges and Successes. Clinical Liver Disease. 18(3). 150–154. 6 indexed citations
12.
Elhence, Anshuman, Sagnik Biswas, Abhinav Anand, et al.. (2021). Predictors of in-hospital Outcomes in Patients With Cirrhosis and Coronavirus Disease-2019. Journal of Clinical and Experimental Hepatology. 12(3). 876–886. 11 indexed citations
13.
Anand, Abhinav, Srikant Mohta, Samagra Agarwal, et al.. (2021). European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis. Journal of Clinical and Experimental Hepatology. 12(1). 52–60. 25 indexed citations
14.
Anand, Abhinav, Sagnik Biswas, Shivanand Gamanagatti, et al.. (2021). Clinical Utility of Transient Elastography in the Management of Patients with Budd-Chiari Syndrome Undergoing Endovascular Intervention. Journal of Vascular and Interventional Radiology. 33(3). 268–277.e3. 2 indexed citations
15.
Shalimar, S., et al.. (2021). Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis. Journal of Clinical and Experimental Hepatology. 12(3). 818–829. 62 indexed citations
16.
Sharma, Sanchit, Samagra Agarwal, Deepak Gunjan, et al.. (2020). Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study. Journal of Clinical and Experimental Hepatology. 11(3). 343–353. 12 indexed citations
17.
Anand, Abhinav, Anshuman Elhence, Vikas Jindal, et al.. (2020). FibroScan–aspartate aminotransferase score in an Asian cohort of non‐alcoholic fatty liver disease and its utility in predicting histological resolution with bariatric surgery. Journal of Gastroenterology and Hepatology. 36(5). 1309–1316. 13 indexed citations
18.
Sharma, Sanchit, Samagra Agarwal, Abhinav Anand, et al.. (2020). Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids. Journal of Clinical and Experimental Hepatology. 11(2). 171–180. 9 indexed citations
19.
Anand, Abhinav, et al.. (2011). MP-10.08 Chest Complications Following Supracostal PCNL may Be Delayed and are More Common on the Right Side. Urology. 78(3). S105–S105. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tudor Cuciureanu Breakdown of academic impact, for papers by Vanesa Bernal Monterde Breakdown of academic impact, for papers by Preetam Nath Breakdown of academic impact, for papers by Truls Sanengen Breakdown of academic impact, for papers by Josephine Grace Breakdown of academic impact, for papers by Neven Franjić Breakdown of academic impact, for papers by Savio John Breakdown of academic impact, for papers by Nobuhiro Hattori Breakdown of academic impact, for papers by Ian Johnston Breakdown of academic impact, for papers by D. Cappello
Rankless by CCL
2026